152 related articles for article (PubMed ID: 26432401)
1. Combined application of ultrasound and SPECT/CT has incremental value in detecting parathyroid tissue in SHPT patients.
Yuan LL; Kan Y; Ma DQ; Yang JG
Diagn Interv Imaging; 2016 Feb; 97(2):219-25. PubMed ID: 26432401
[TBL] [Abstract][Full Text] [Related]
2. The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism.
Zhen L; Li H; Liu X; Ge BH; Yan J; Yang J
Nucl Med Commun; 2013 May; 34(5):439-44. PubMed ID: 23458854
[TBL] [Abstract][Full Text] [Related]
3. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism.
Yang J; Hao R; Yuan L; Li C; Yan J; Zhen L
AJR Am J Roentgenol; 2014 Jan; 202(1):180-4. PubMed ID: 24370142
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
Patel CN; Salahudeen HM; Lansdown M; Scarsbrook AF
Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
[TBL] [Abstract][Full Text] [Related]
5. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience.
Ciappuccini R; Morera J; Pascal P; Rame JP; Heutte N; Aide N; Babin E; Reznik Y; Bardet S
Clin Nucl Med; 2012 Mar; 37(3):223-8. PubMed ID: 22310246
[TBL] [Abstract][Full Text] [Related]
6. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
[TBL] [Abstract][Full Text] [Related]
7. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ⁹⁹mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ⁹⁹mTc-sestamibi scintigraphy, SPECT, US and CT.
Kim YI; Jung YH; Hwang KT; Lee HY
Ann Nucl Med; 2012 Dec; 26(10):804-10. PubMed ID: 22875576
[TBL] [Abstract][Full Text] [Related]
9. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients.
Serra A; Bolasco P; Satta L; Nicolosi A; Uccheddu A; Piga M
Radiol Med; 2006 Oct; 111(7):999-1008. PubMed ID: 17021682
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of dual-phase SPECT/CT scintigraphy based on transport kinetics of 99mTc-sestamibi confirmed with histopathological findings in patients with secondary hyperparathyroidism - practical consideration.
Listewnik MH; Piwowarska-Bilska H; Safranow K; Ostrowski M; Iwanowski J; Chosia M; Birkenfeld B
Nucl Med Rev Cent East Eur; 2020; 23(2):71-77. PubMed ID: 33007093
[TBL] [Abstract][Full Text] [Related]
11. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis.
Wong KK; Fig LM; Gross MD; Dwamena BA
Nucl Med Commun; 2015 Apr; 36(4):363-75. PubMed ID: 25642803
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
[TBL] [Abstract][Full Text] [Related]
15. The role of
Jiang SQ; Yang T; Zou Q; Xu L; Ye T; Kang YQ; Li WR; Jiao J; Zhang Y
BMC Med Imaging; 2020 Oct; 20(1):115. PubMed ID: 33059621
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
17. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.
Wang TS; Cheung K; Farrokhyar F; Roman SA; Sosa JA
Surgery; 2011 Dec; 150(6):1286-94. PubMed ID: 22136852
[TBL] [Abstract][Full Text] [Related]
18. The role of preoperative ultrasound, contrast-enhanced ultrasound, and 99mTc-MIBI scanning with single-photon emission computed tomography/X-ray computed tomography localization in refractory secondary hyperparathyroidism.
Li X; Li J; Li Y; Wang H; Yang J; Mou S; Zhou M; Jiang C; Ning C
Clin Hemorheol Microcirc; 2020; 75(1):35-46. PubMed ID: 31868660
[TBL] [Abstract][Full Text] [Related]
19. Value of 99mTc-MIBI SPECT/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma.
Guo R; Wang J; Zhang M; Zhang M; Meng H; Zhang Y; Li B
Nucl Med Commun; 2017 Aug; 38(8):676-682. PubMed ID: 28614134
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of anterior 180°
Cheng JL; Hsu CC; Wang PW; Sung KC; Chiu NT; Chiu LY; Huang YC
Ann Nucl Med; 2021 Feb; 35(2):203-210. PubMed ID: 33389667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
